Trump administration withdraws autism drug recommendation

The Trump administration has retracted its recommendation for using leucovorin to treat autism, citing a lack of sufficient evidence for its effectiveness. This decision marks a reversal of previous guidance regarding the drug's use for patients with autism.
Based on reporting by haarlemsdagblad. Translated and condensed by LocalHeadlines.



